CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefotaxime And Dextrose 2.4% In Plastic Container, and what generic alternatives are available?
Cefotaxime And Dextrose 2.4% In Plastic Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?
- What are the global sales for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?
Summary for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 37 |
| DailyMed Link: | CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | Phase 4 |
| Cairo University | Phase 4 |
| Dr. Promise Tamunoipiriala Jaja | Phase 2 |
See all CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050792-001 | Jul 29, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
